Genmab | Spese Operative



Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
Almirall EUR 195.38M 68.92M 2024-06
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.78B 401M 2024-12
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Bayer EUR 8.2B 5.59B 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Demant DKK 9B 4.47B 2024-12
Exelixis USD 403.55M 82K 2025-01
Fresenius Medical Care EUR 4.83B 528.89M 2024-12
Galapagos EUR 138.22M 24.07M 2024-12
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
GN Store Nord DKK 4.32B 613M 2024-12
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Insmed USD 334.86M 28M 2024-12
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.17B 391M 2024-09
Novartis USD 11.28B 1.73B 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 10.07B 969M 2024-09
UCB EUR 1.23B 1.31B 2024-06



Genmab Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.